arrow
M

Mathias Jucker

german center for neurodegenerative diseases
H指数:93
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of amyloid chronicity and EYO in autosomal dominant Alzheimer's disease

常染色体显性遗传性阿尔茨海默病中淀粉样蛋白慢性程度与EYO的比较

2025-10-250
OAAI
The relationship of soluble tau species with Alzheimer's disease amyloid plaque removal and tau pathology

可溶性tau物种与阿尔茨海默病淀粉样斑块清除及tau病理的关系

2025-09-230
OAAI
EnsembleAge: enhancing epigenetic age assessment with a multi-clock framework

EnsembleAge:利用多时钟框架增强表观遗传年龄评估

2025-08-060
OA
Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial

gantenerumab在DIAN-TU-001试验中对神经影像生物标志物的区域性影响

2025-07-140
OA
Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease

显性遗传阿尔茨海默病中gantenerumab或solanezumab试验的免疫组化评估

2025-06-030
OAAI
Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer's disease (vol 8, pg 1265, 2024)

随着常染色体显性阿尔茨海默病(vol 8, pg 1265, 2024)中痴呆严重程度的增加,中心节点破坏也在增加。

2025-04-280
OA
Early increase of the synaptic blood marker β-synuclein in asymptomatic autosomal dominant Alzheimer's disease

无症状常染色体显性遗传性阿尔茨海默病患者中突触血标志物β-突触核蛋白的早期增加

2025-04-100
OAAI
Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer's disease
2024-12-100
OAAI
Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer's disease

轴突损伤和炎症反应是小世界价值下降的生物学相关性: 常染色体显性阿尔茨海默病的队列研究

2024-10-091
OAAI
Association of Resilience-Related Life Experiences on Variability on Age of Onset in Dominantly Inherited Alzheimer Disease
2024-10-080
PRE
Longitudinal associations between exercise and biomarkers in autosomal dominant Alzheimer's disease

运动与常染色体显性阿尔茨海默病生物标志物之间的纵向关联

2024-09-260
OA
Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease

显性遗传与散发性早发性阿尔茨海默病的分子神经影像学

2024-05-032
OAAI
α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden

Α-突触核蛋白种子扩增测定法可检测常染色体显性遗传性阿尔茨海默氏病的Lewy体共病理,并取决于Lewy病理负担

2024-04-263
OA
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease
2024-02-231
OAAI
Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage
2024-02-211
OA